Aging US Demographics And AI Adoption Will Transform Healthcare Services

Published
10 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$30.00
29.1% undervalued intrinsic discount
14 Aug
US$21.27
Loading
1Y
6.9%
7D
3.4%

Author's Valuation

US$30.0

29.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on30 Apr 25

Shared on23 Apr 25
Fair value Decreased 0.13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.28%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.20%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 2.64%

AnalystConsensusTarget has decreased revenue growth from 12.1% to 10.1%, decreased profit margin from 3.0% to 2.6% and increased future PE multiple from 58.8x to 72.1x.